AIM ImmunoTech Inc.

AMEX: AIM · Real-Time Price · USD
2.52
-0.05 (-1.95%)
At close: Aug 15, 2025, 3:58 PM
2.65
5.16%
After-hours: Aug 15, 2025, 07:30 PM EDT

AIM ImmunoTech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
898K 1.7M 915K 3.55M 3.29M 5.44M 15.26M 21.04M 23.39M 27.05M 29.76M 34.45M 28.99M 32.09M 37.35M 41.14M 48.77M
Short-Term Investments
1.35M 2.28M 6.29M 6.51M 7.65M 7.63M 7.17M 7.36M 7.45M 7.14M 6.99M 7.32M 15.55M 16.18M 499K n/a 1.16M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -25.02M 15.81M 16.14M 13.66M
Other Long-Term Assets
745K 1.11M 2.72M 2.05M 1.69M 1.69M 2.1M 1.78M 1.46M 1.2M 2.14M 1.81M 1.51M -23.7M 1.25M 1.18M 929K
Receivables
19K n/a n/a n/a n/a 1.18M 48K 33K 1.76M 1.68M n/a n/a 1.64M 1.64M 28K 28K 1.12M
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.9M n/a n/a n/a n/a
Other Current Assets
318K 199K 368K 300K 364K 1.18M 263K 438K 548K 455K 3.6M 3.9M 3.9M 304K 161K 155K n/a
Total Current Assets
2.58M 4.18M 7.57M 10.36M 11.31M 14.56M 22.74M 28.87M 33.16M 36.32M 41.15M 46.05M 50.38M 50.21M 38.04M 41.33M 51.22M
Property-Plant & Equipment
652K 726K 770K 809K 881K 824K 863K 926K 947K 1.02M 984K 1.02M 281K 4.2M 6.14M 6.3M 6.48M
Goodwill & Intangibles
2.27M 2.59M 2.53M 2.49M 2.31M 2.31M 2.15M 2.04M 1.9M 1.94M 2.01M 2.01M 1.99M 1.97M 1.84M 1.78M 1.8M
Total Long-Term Assets
3.66M 4.43M 6.02M 5.35M 4.88M 4.86M 5.12M 4.75M 4.3M 4.17M 5.13M 4.84M 3.77M 7.49M 25.04M 25.4M 22.87M
Total Assets
6.25M 8.61M 13.59M 15.71M 16.19M 19.42M 27.86M 33.62M 37.46M 40.49M 46.28M 50.88M 54.16M 57.7M 63.08M 66.72M 74.09M
Account Payables
6.94M 6.38M 6.26M 5.46M 6.57M 6.44M 2.79M 2.15M 963K 377K 957K 712K 378K 198K 369K 451K 189K
Deferred Revenue
n/a n/a 999.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 264K
Short-Term Debt
1.95M 2.31M 2.59M 2.35M 1.62M n/a 207K n/a 178K n/a 171K 154K 60K 37K 36K 52K n/a
Other Current Liabilities
1K 1K 1K n/a n/a 1.57M 1.49M n/a 501K 1K 1.56M 320K 254K 400K 322K 305K 716K
Total Current Liabilities
9.77M 9.54M 10.1M 8.84M 9.88M 8.65M 4.72M 2.88M 1.84M 1.36M 2.9M 1.37M 766K 673K 767K 876K 970K
Long-Term Debt
n/a n/a 139K 283K 950K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1K 4K 35K 158K 209K 217K
Total Long-Term Liabilities
338K 395K 576K 771K 1.49M 531.82K 543K 597K 636K 659K 695K 736K 88K 147K 266K 314K 2.15M
Total Liabilities
10.11M 9.93M 10.68M 9.61M 11.36M 9.18M 5.26M 3.48M 2.47M 2.02M 3.59M 2.1M 854K 820K 1.03M 1.19M 3.12M
Total Debt
2.52M 2.94M 3.4M 3.36M 3.35M 718K 750K 803K 814K 837K 866K 889K 144K 149K 144K 157K 2.22M
Common Stock
72K 66K 59K 57K 50K 49K 48K 48K 48K 48K 48K 48K 48K 48K 48K 48K 48K
Retained Earnings
-430.53M -426.83M -420.86M -417.16M -415.32M -409.51M -396.93M -389.12M -384.21M -380.55M -376.16M -369.77M -364.92M -361.1M -355.25M -351.43M -345.55M
Comprehensive Income
n/a n/a n/a n/a -689K -0.00 -690K n/a n/a n/a -0.00 n/a n/a n/a -250K -247K -208K
Shareholders Equity
-3.86M -1.32M 2.91M 6.1M 4.83M 10.23M 22.6M 30.14M 34.99M 38.47M 42.7M 48.78M 53.3M 56.88M 62.05M 65.53M 70.97M
Total Investments
1.35M 2.28M 6.29M 6.51M 7.65M 7.63M 7.17M 7.36M 7.45M 7.14M 6.99M 7.32M 15.55M 16.18M 16.31M 16.14M 14.83M